With an investment of $200 million from USAID, Johns Hopkins Medicine launches the Supporting, Mobilizing and Accelerating Research for Tuberculosis Elimination (SMART4TB) project. This five-year project will support studies to improve tuberculosis (TB) detection methods, treatments, containment strategies, and prevention, as well as strengthen research efforts in 24 countries with high TB burdens.
As we know all too well at KNCV, TB causes unbelievable suffering worldwide and 1.5 million deaths every year. To address this crisis, USAID awarded Johns Hopkins Medicine $200 million for leading this international collaboration for fund research on TB diagnostics, treatment and prevention. “With this incredible award, we can work with partners around the world to make a big impact on the global goal of TB elimination,” says Amita Gupta, M.D., M.H.S., director of the Division of Infectious Diseases and professor of medicine at the Johns Hopkins University School of Medicine.
The SMART4TB project will be led by Johns Hopkins University School of Medicine, and supported by consortium partners KNCV Tuberculosis Foundation, University of California, San Francisco, Center for Tuberculosis, the Elizabeth Glaser Pediatric AIDS Foundation, the Treatment Action Group, Kyrgyz State Medical Academy, Walimu, PHRU/Wits Health Consortium, YRG Care and the VICTORY Network. We are beyond exited to join this prestige group of organizations is this promising collaboration.